View as an RSS Feed
View Sujan Lahiri's Articles BY TICKER:
ZBB Energy Corporation: A Deeply Oversold Renewable Energy Stock With 125% Upside
- ZBB Energy develops and sells advanced energy storage solutions based on its patented zinc-bromide grid storage technology.
- Grid storage in large quantities is a worldwide megatrend; ZBB Energy is one of the few that holds key technology.
- Multiple catalysts should drive shares substantially higher.
- Share price is at all-time lows mainly due to market broad energy panic, even causing the market cap to dip below net cash level.
- Strong insider buying should warrant attention.
Why Image Sensing Systems Could Double Before Year End
- Image Sensing Systems has been driven down to deeply undervalued low levels due to temporary headwinds and overly aggressive short selling.
- Multiple positive developments prove a successful turn-around is underway.
- Key insiders are buying.
- Renewed product line-up could have huge impact on share price.
- Major short squeeze could amplify share price appreciation.
6 Reasons Aradigm Corporation Is An Excellent Risk Vs. Reward Opportunity
- Aradigm has a unique pipeline in development targeting undertreated respiratory diseases.
- There is almost no coverage to be found on Aradigm. Wall Street has yet to discover this company, which is rare for a Phase III biotech stock.
- Aradigm’s excellent financials, partnership with a major pharmaceutical company and stable share price significantly reduce downside risk.
- Aradigm looks severely undervalued. This reduces downside risk too, and amplifies upside potential.
ZTE Settlement Could Drive Vringo Shares Substantially Higher
- Odds are ZTE will settle with Vringo.
- A ZTE settlement could have a major impact on share price.
- Vringo has filed another lawsuit against a blue chip company.
- Shares are trading at a strong technical bottom, creating an excellent entry point.
MagneGas: An Undervalued Opportunity In Alternative Energy
- MagneGas is a virtually unknown small alternative energy play listed on the NASDAQ.
- Its technology could have a profound impact on the alternative energy industry.
- We believe the company is currently undervalued, and shares should trade higher soon.
Why IsoRay Presents A Very Compelling Risk/Reward Opportunity
- IsoRay's Cesium 131 cancer therapy is FDA approved, and superior to any cancer therapy by many measures, like the unmatched high 98% to 100% efficacy rate.
- IsoRay has a monopoly on the Cesium 131 brachytherapy market, and a recent valid CE Mark opens the door for significant revenue growth.
- Broad unawareness and warrant conversion pushed shares down to an irrationally low level, creating a very favorable risk vs reward investment opportunity.
- Intellicheck Mobilisa: A $0.40 Stock That Should Be Trading At $2
- Cel-Sci's Undervaluation Is Market Irrationality At Its Best
- Bioanalytical Systems: A Hidden Gem Among Profitable Biotech Companies
- Lightbridge: Check Out This $1.40 Stock Everybody Else Is Ignoring
- Aeterna Zentaris: Mispriced $1 Biotech Stock With Limited Downside Risk And Big Upside Potential
- CodeSmart's Dramatic Undervaluation Provides Multi-Bagger Opportunity
- Netflix: The Netscape Navigator Of 2014
- Ikanos Communication's Massive Growth Potential Is Bound To Drive Shares Higher
- Low Downside, Multi-Bagger Upside: MER Telemanagement Solutions Is The Cloud Tech Play To Own
- A Large Private Equity Firm Is Accumulating Shares Of Mecox Lane, Smart Investors Do The Same
- Forgotten Small Cap Digirad Corporation: Endless Stream Of Insider Buying And A Key Trial Win Indicate Deep Undervaluation
- MeetMe: Can You Find A Cheaper Social Media Company?
- Sell iBio As Dilution Risk Is Running High And Insiders Are Selling Aggressively
- Canadian Solar's Parabolic Rise Provides Excellent Short Opportunity
- Blue Calypso: An Overlooked Patent Play, Shares Offer Multi-Bagger Opportunity
- Plug Power: A Small Fuel Cell Pioneer Nearing Profitability And Revenue Multiplication
- Isoray: Technological Monopoly In The Cancer Therapy Market Provides Multi-Bagger Opportunity
- Medgenics: An Overlooked Biotech Stock That Could Be A Compelling Risk/Reward Investment
- Hipcricket: A Hidden Gem In The World Of Mobile Advertising
- The Gaming Industry Is Hot Again: This Mad Small Cap Is Ready For A Triple-Digit Rise